Peripheral blood mononuclear cells as in vivo model for dietary intervention induced systemic oxidative stress

Food Chem Toxicol. 2014 Oct:72:178-86. doi: 10.1016/j.fct.2014.07.024. Epub 2014 Jul 22.

Abstract

Our aim was to assess the use of peripheral blood mononuclear cells (PBMC) as an in vivo cellular model to evaluate diet-induced changes in the oxidative stress status by analyzing the gene expression pattern of NADPH-oxidase subunits and antioxidant genes. A randomized, controlled trial assigned metabolic syndrome patients to 4 diets for 12 weeks each: (i) high-saturated fatty acid (HSFA), (ii) high-monounsaturated fatty acid, and (iii), (iv) two low-fat, high-complex carbohydrate diets supplemented with n-3 polyunsaturated fatty acids or placebo. A fat challenge reflecting the fatty acid composition as the original diets was conducted post-intervention. The mRNA levels of gp91(phox) (P<0.001), p22(phox) (P=0.005), p47(phox) (P=0.001) and p40(phox) (P<0.001) increased at 2h after the intake of the HSFA meal. The expression of SOD1, SOD2, GSR, GPx1, GPX4, TXN, TXNRD1 and Nrf2 increased after the HSFA meal (p<0.05). In contrast, the expression of these genes remained unaltered in response to the other dietary interventions. Our results suggest that the increased expression of antioxidant genes in PBMC seems to be due to the response to the postprandial oxidative stress generated mainly in adipose tissue after the consumption of an HSFA diet.

Keywords: Diet; LIPGENE study; Metabolic syndrome; Mononuclear cells; Oxidative stress; Postprandial state.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism
  • Adult
  • Aged
  • Antioxidants / pharmacology
  • Diet, High-Fat*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Supplements
  • Fatty Acids / administration & dosage
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Omega-3 / administration & dosage
  • Female
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Glutathione Peroxidase GPX1
  • Humans
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Metabolic Syndrome / diet therapy
  • Metabolic Syndrome / genetics
  • Middle Aged
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress / drug effects*
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Postprandial Period / drug effects
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase-1
  • Thioredoxin Reductase 1 / genetics
  • Thioredoxin Reductase 1 / metabolism

Substances

  • Antioxidants
  • Dietary Carbohydrates
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Fatty Acids, Omega-3
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • SOD1 protein, human
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • superoxide dismutase 2
  • NADPH Oxidases
  • TXNRD1 protein, human
  • Thioredoxin Reductase 1
  • Glutathione Peroxidase GPX1
  • GPX1 protein, human